Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Liverani C, Spadazzi C, Ibrahim T, Pieri F, Foca F, Calabrese C, De Vita A, Miserocchi G, Cocchi C, Vanni S, Ercolani G, Cavaliere D, Ranallo N, Chiadini E, Prisinzano G, Severi S, Sansovini M, Martinelli G, Bongiovanni A, Mercatali L. Liverani C, et al. Among authors: vanni s. Front Endocrinol (Lausanne). 2023 Jan 20;13:1045038. doi: 10.3389/fendo.2022.1045038. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743926 Free PMC article.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: vanni s. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature.
Miserocchi G, Bassi M, De Luca G, Calpona S, De Rosa F, Bongiovanni A, Parisi E, Di Menna G, De Vita A, Liverani C, Spadazzi C, Cocchi C, Vanni S, Capelli L, Magnani M, Meccariello G, Vicini C, Campobassi A, Mercatali L, Ibrahim T. Miserocchi G, et al. Among authors: vanni s. Front Oncol. 2023 Sep 18;13:1245043. doi: 10.3389/fonc.2023.1245043. eCollection 2023. Front Oncol. 2023. PMID: 37795450 Free PMC article.
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.
Guerrieri AN, Bellotti C, Penzo M, Columbaro M, Pannella M, De Vita A, Gambarotti M, Mercatali L, Laranga R, Dozza B, Vanni S, Corsini S, Frisoni T, Miserocchi G, Ibrahim T, Lucarelli E. Guerrieri AN, et al. Among authors: vanni s. BMC Cancer. 2023 Dec 6;23(1):1194. doi: 10.1186/s12885-023-11658-9. BMC Cancer. 2023. PMID: 38057796 Free PMC article.
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models.
Becattini C, Vedovati MC, Colombo S, Vanni S, Abrignani MG, Scardovi AB, Marrazzo A, Borselli M, Barchetti M, Fabbri A, Dentali F, Maggioni AP, Agnelli G, Gulizia MM; COPE Investigators(∗). Becattini C, et al. Among authors: vanni s. J Thromb Haemost. 2024 May 27:S1538-7836(24)00302-7. doi: 10.1016/j.jtha.2024.04.025. Online ahead of print. J Thromb Haemost. 2024. PMID: 38810699 Free article.
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events.
De Luca L, Pugliese FR, Susi B, Navazio A, Corda M, Fabbri A, Scicchitano P, Voza A, Vanni S, Bilato C, Geraci G, Gabrielli D, Grimaldi M, Colivicchi F, De Iaco F, Oliva F. De Luca L, et al. Among authors: vanni s. Eur Heart J Suppl. 2024 May 16;26(Suppl 2):ii211-ii220. doi: 10.1093/eurheartjsupp/suae033. eCollection 2024 Apr. Eur Heart J Suppl. 2024. PMID: 38784674 Free PMC article.
Lipid scrambling is a general feature of protein insertases.
Li D, Rocha-Roa C, Schilling MA, Reinisch KM, Vanni S. Li D, et al. Among authors: vanni s. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2319476121. doi: 10.1073/pnas.2319476121. Epub 2024 Apr 15. Proc Natl Acad Sci U S A. 2024. PMID: 38621120
[ANMCO/SIMEU Consensus document on the use of reversal agents of antithrombotic therapies in patients with active bleeding or at high-risk of major bleeding events].
De Luca L, Pugliese FR, Susi B, Navazio A, Corda M, Fabbri A, Scicchitano P, Voza A, Vanni S, Bilato C, Geraci G, Gabrielli D, Grimaldi M, Colivicchi F, De Iaco F, Oliva F. De Luca L, et al. Among authors: vanni s. G Ital Cardiol (Rome). 2024 Jan;25(1):60-69. doi: 10.1714/4165.41594. G Ital Cardiol (Rome). 2024. PMID: 38141000 Italian.
350 results